Published in Br Med J on September 02, 1978
Functional bowel disorders and functional abdominal pain. Gut (1999) 7.63
Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain (2009) 5.62
Irritable bowel syndrome in the general population. BMJ (1992) 5.26
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects. PLoS One (2015) 3.37
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut (2000) 3.26
Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ (1990) 2.86
Aerobic work capacity in patients with chronic fatigue syndrome. BMJ (1990) 2.86
Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut (1997) 2.77
Psychological factors in the irritable bowel syndrome. Gut (1987) 2.73
Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci (2002) 2.46
Functional abdominal pain: further evidence that whole gut is affected. Br Med J (Clin Res Ed) (1982) 2.41
Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut (1983) 2.39
Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut (1992) 2.15
Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11
Irritable bowel, irritable body, or irritable brain? BMJ (1995) 2.11
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut (2000) 2.09
Effect of cholecystectomy on bowel function: a prospective, controlled study. Gut (1999) 2.08
The epidemiology of irritable bowel syndrome. Clin Epidemiol (2014) 2.06
Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract (2004) 2.03
Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut (2003) 1.98
The functional gastrointestinal disorders and the Rome II process. Gut (1999) 1.97
The irritable bowel. Gut (1984) 1.96
Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut (1997) 1.95
Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants. CMAJ (1999) 1.89
How well does stool form reflect colonic transit? Gut (1996) 1.77
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut (2004) 1.76
Reasons for consultation in irritable bowel syndrome: symptoms and patient characteristics. Br J Gen Pract (1992) 1.75
First clinical judgment by primary care physicians distinguishes well between nonorganic and organic causes of abdominal or chest pain. J Gen Intern Med (1997) 1.74
Non-acute abdominal complaints in general practice: diagnostic value of signs and symptoms. Br J Gen Pract (1995) 1.71
Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut (1992) 1.70
Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut (1990) 1.68
Intestinal transit in anxiety and depression. Gut (1996) 1.67
Symptoms and stool patterns in patients with ulcerative colitis. Gut (1988) 1.66
Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease. Gut (1984) 1.64
Variability of gastrointestinal transit in healthy women and men. Gut (1996) 1.63
Oesophageal motility in the irritable bowel syndrome. Br Med J (Clin Res Ed) (1981) 1.63
Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut (1986) 1.63
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut (1998) 1.62
Heartburn and globus in apparently healthy people. Can Med Assoc J (1982) 1.58
Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut (1998) 1.57
IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci (2004) 1.53
Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax (2006) 1.52
Increased cholecystectomy rate in the laparoscopic era: a study of the potential causative factors. Surg Endosc (2006) 1.50
Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria. Patient Prefer Adherence (2008) 1.46
Evidence for the ambiguity of the term constipation: the role of irritable bowel syndrome. Gut (1994) 1.44
Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut (2001) 1.43
A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms. Dig Dis Sci (2015) 1.43
Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ (2005) 1.42
A database on dyspepsia. Gut (1994) 1.41
Management of irritable bowel syndrome. Postgrad Med J (2003) 1.40
Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia. Gut (1992) 1.38
More accurate diagnosis of irritable bowel syndrome by the use of 'non-colonic' symptomatology. Gut (1991) 1.37
Familial aggregation of irritable bowel syndrome: a prospective study. Gut (2003) 1.33
Abuse, dissociation, and somatization in irritable bowel syndrome: towards an explanatory model. J Behav Med (2003) 1.29
Selective affective biasing in recognition memory in the irritable bowel syndrome. Gut (1993) 1.28
Comparison of gastrointestinal symptoms in colorectal carcinoma patients and community controls with respect to age. Gut (1994) 1.25
Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trial. World J Gastroenterol (2005) 1.25
Irritable bowel syndrome: prevalence, prognosis and consequences. CMAJ (1986) 1.24
Life events, psychiatric illness and the irritable bowel syndrome. Gut (1987) 1.24
Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol (2010) 1.23
Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It? J Neurogastroenterol Motil (2015) 1.23
Irritable bowel syndrome--a safe diagnosis? Br Med J (Clin Res Ed) (1982) 1.21
The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls. Gastroenterology (2011) 1.18
Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut (1996) 1.16
Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale. Aliment Pharmacol Ther (2009) 1.16
Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study. Gut (1987) 1.15
Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol (2014) 1.14
Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol (2010) 1.14
Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14
Perceptual responses in patients with inflammatory and functional bowel disease. Gut (2000) 1.13
Comorbid clinical conditions in chronic fatigue: a co-twin control study. J Gen Intern Med (2001) 1.13
Abdominal distension in female patients with irritable bowel syndrome: exploration of possible mechanisms. Gut (1991) 1.12
Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). BMC Gastroenterol (2007) 1.10
Irritable bowel syndrome: a clinical review. World J Gastroenterol (2014) 1.10
Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study. Gut (1991) 1.09
Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort. Respir Res (2006) 1.09
Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut (2006) 1.08
Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model. Dig Dis Sci (2014) 1.08
Pain from rectal distension in women with irritable bowel syndrome: relationship to sexual abuse. Dig Dis Sci (1997) 1.08
"Rectal dissatisfaction" in the irritable bowel syndrome. A manometric and radiological study. Int J Colorectal Dis (1986) 1.07
Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol (2007) 1.07
Major life event stress and dyspepsia of unknown cause: a case control study. Gut (1986) 1.07
Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms. Dig Dis Sci (1997) 1.06
Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study. Gut (1990) 1.06
Ambulatory small intestinal motility in 'diarrhoea' predominant irritable bowel syndrome. Gut (1994) 1.05
Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev (2012) 1.05
Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J (2007) 1.04
The effect of obesity on medical students' approach to patients with abdominal pain. J Gen Intern Med (2001) 1.04
Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia. BMJ (1992) 1.02
Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci (2011) 1.02
Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1. Int J Prev Med (2012) 1.01
Chronic upper abdominal pain: site and radiation in various structural and functional disorders and the effect of various foods. Gut (1992) 1.01
Irritable bowel syndrome. Diagnosis in the managed care era. Dig Dis Sci (1997) 1.00
Applying case definition criteria to irritable bowel syndrome. Clin Med Res (2008) 0.99
Anamnestic and psychological features in diagnosis and prognosis of functional abdominal complaints: a prospective study. Gut (1989) 0.99
Sleep and duodenal motor activity in patients with severe non-ulcer dyspepsia. Gut (1994) 0.98
Frequency of "functional" gastrointestinal disorders. Lancet (1977) 5.73
The irritable bowel syndrome. Part I: clinical spectrum. Clin Gastroenterol (1977) 5.28
The irritable bowel syndrome. Gastroenterology (1977) 4.64
Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol (1997) 8.81
Functional bowel disorders in apparently healthy people. Gastroenterology (1980) 8.52
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
Functional bowel disorders and functional abdominal pain. Gut (1999) 7.63
Is extrinsic sugar a vehicle for dietary fat? Lancet (1995) 4.05
Effects of increased dietary fibre on intestinal transit. Lancet (1973) 3.49
Value of necropsy in acquired immunodeficiency syndrome. Lancet (1988) 3.39
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut (2000) 3.26
Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet (1977) 3.08
Casual attendances at an accident department and a health centre. Br Med J (1971) 2.98
Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J (1979) 2.93
Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ (1990) 2.86
A comparison of work-sampling and time-and-motion techniques for studies in health services research. Health Serv Res (1993) 2.83
An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol (2001) 2.30
Perceptions and reactions of the public to diarrhoea. J R Soc Health (1993) 2.22
Increasing frequency of gall bladder operations in the Bristol clinical area. Br Med J (1972) 2.20
Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber) Gastroenterology (1992) 2.19
Gall stones in patients with disorders of the terminal ileum and disturbed bile salt metabolism. Br Med J (1969) 2.17
The effect of wheat bran on intestinal transit. Gut (1975) 2.10
The importance of keeping bile salts in their place. Gut (1969) 2.08
Effect of cholecystectomy on bowel function: a prospective, controlled study. Gut (1999) 2.08
The MD thesis in the training of a consultant physician. J R Coll Physicians Lond (1992) 2.03
The potential for using non-physicians to compensate for the reduced availability of residents. Acad Med (1992) 2.00
The irritable bowel. Gut (1984) 1.96
Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants. CMAJ (1999) 1.89
Food fibre as an obstacle to energy intake. Lancet (1973) 1.87
The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med (1992) 1.85
The epidemiology of gallstones and suggested aetiology. Clin Gastroenterol (1973) 1.83
Variability of colonic function in healthy subjects. Gut (1978) 1.82
Does uncomplicated diverticular disease produce symptoms? Dig Dis Sci (1982) 1.82
Wheat fibre and irritable bowel syndrome. A controlled trial. Lancet (1977) 1.80
Infant feeding and subsequent risk of atopic eczema. Arch Dis Child (1985) 1.67
Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors. Gut (1986) 1.64
Smoking, sugar, and inflammatory bowel disease. Br Med J (Clin Res Ed) (1985) 1.64
Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease. Gut (1984) 1.64
Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol (2002) 1.63
Gallbladder inertia and sluggish enterohepatic circulation of bile-salts in coeliac disease. Lancet (1971) 1.62
Heartburn and globus in apparently healthy people. Can Med Assoc J (1982) 1.58
The effect of cholecystectomy on bile salt metabolism. Gut (1973) 1.56
Clinical management of intractable constipation. Ann Intern Med (1994) 1.52
Colonscopy for investigation of unexplained rectal bleeding. Lancet (1978) 1.51
The effect on intestinal transit and the feces of raw and cooked bran in different doses. Am J Clin Nutr (1976) 1.50
Left atrial myxoma with multiple emboli and hypercalcemia. Can Med Assoc J (1966) 1.46
Evidence for the ambiguity of the term constipation: the role of irritable bowel syndrome. Gut (1994) 1.44
Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate. Endoscopy (1988) 1.43
The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived form treated and untreated conception cycles. Fertil Steril (1982) 1.42
The irritable colon. Can Med Assoc J (1974) 1.41
Oral fibre. Can Med Assoc J (1975) 1.39
THE MENACE OF THE DUSTY TRADES. Am J Public Health (N Y) (1917) 1.39
Bile salt metabolism in patients with gallstones in functioning gallbladders. Gut (1973) 1.39
Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet. Br Med J (1979) 1.39
The effect of wheat bran upon bile salt metabolism and upon the lipid composition of bile in gallstone patients. Am J Dig Dis (1976) 1.36
Enterohepatic circulation of C14-labeled bile salts in disorders of the distal small bowel. Gastroenterology (1968) 1.36
University of Ottawa modified systems program. J Med Educ (1977) 1.34
The role of dietary fiber in satiety, glucose, and insulin: studies with fruit and fruit juice. Am J Clin Nutr (1981) 1.32
Irritable bowel syndrome: the view from general practice. Eur J Gastroenterol Hepatol (1997) 1.32
How trustworthy are bowel histories? Comparison of recalled and recorded information. Br Med J (1976) 1.29
Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up. Gut (1988) 1.26
Deoxycholic acid and the pathogenesis of gall stones. Gut (1988) 1.26
Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut (1997) 1.25
Miliary Crohn's disease. Gut (1967) 1.24
Irritable bowel syndrome: prevalence, prognosis and consequences. CMAJ (1986) 1.24
Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther (2002) 1.20
Diet and ulcerative colitis. Br Med J (1980) 1.20
Proctalgia fugax. J R Coll Physicians Lond (1980) 1.18
Effects of a new, concentrated wheat fibre preparation on intestinal transit, deoxycholic acid metabolism and the composition of bile. Gut (1986) 1.14
Aetiology of acute appendicitis. Br Med J (Clin Res Ed) (1987) 1.14
Effect of bran on blood lipids and calcium. Lancet (1974) 1.13
Alteration of bile salt metabolism by dietary fibre (bran). Br Med J (1973) 1.13
A relation between high-density-lipoprotein cholesterol and bile cholesterol saturation. Br Med J (Clin Res Ed) (1981) 1.13
Effect of pectin on serum lipids and lipoproteins, whole-gut transit-time, and stool weight. Lancet (1976) 1.12
Lipid composition of bile in diabetics and obesity-matched controls. Gut (1979) 1.10
Nonulcer dyspepsia. Can Med Assoc J (1984) 1.08
The effect of coeliac disease upon bile salts. Gut (1973) 1.08
"Rectal dissatisfaction" in the irritable bowel syndrome. A manometric and radiological study. Int J Colorectal Dis (1986) 1.07
Lactobacillus acidophilus (enpac) in treatment of hepatic encephalopathy. Br Med J (1966) 1.07
Empyema of the gall bladder - reappraisal of a neglected disease. Gut (1983) 1.07
Estimation of cholesterol in bile: assessment of an enzymatic method. Clin Chim Acta (1980) 1.06
Osteomalacia associated with cholestyramine therapy for postileectomy diarrhea. Gastroenterology (1972) 1.06
Effects of fasting on the composition of gallbladder bile. Gut (1980) 1.05
Final year medical students' knowledge of practical nutrition. J R Soc Med (1992) 1.05
Pruritic effect of bile salts. Br Med J (1974) 1.05
Bran and bile: time-course of changes in normal young men given a standard dose. Scand J Gastroenterol (1978) 1.04
Do colonic bacteria contribute to cholesterol gall-stone formation? Effects of lactulose on bile. Br Med J (Clin Res Ed) (1981) 1.03
A simplified procedure for the analysis of cholesterol, phospholipids and bile salts in human bile. Clin Chim Acta (1978) 1.02
Glucose and insulin responses to manufactured and whole-food snacks. Am J Clin Nutr (1987) 1.02
Is rectal biopsy necessary in irritable bowel syndrome? Am J Gastroenterol (1992) 1.02
Diet and gall stones: effects of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism. Gut (1983) 1.02
A new syndrome with pigmentation, scleroderma, gynaecomastia, Raynaud's phenomenon and peripheral neuropathy. Br J Dermatol (1978) 1.02
Disturbances of bile acid metabolism in intestinal disease. Clin Gastroenterol (1977) 1.01
Non-fatal portal pyaemia complicating Crohn's disease of the terminal ileum. Gut (1994) 1.01
Increased ratio of glycine- to taurine-conjugated bile salts in patients with ileal disorders. Gastroenterology (1969) 1.01